DUBLIN, Dec. 20, 2023 /PRNewswire/ -- Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company
will webcast its corporate presentation at the 42nd
Annual J.P. Morgan Healthcare Conference. Bruce Cozadd, chairman and chief executive
officer, will provide an overview of the company and a business and
financial update on Monday, January 8,
2024, at 2:15 p.m. PST /
10:15 p.m. GMT.
A live audio webcast of the presentation may be accessed via the
Investors section of the Jazz Pharmaceuticals website at
https://investor.jazzpharma.com/investors/events-presentations. A
replay of the webcast will be available on the website for 30 days
following the conference.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals
plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose
purpose is to innovate to transform the lives of patients and their
families. We are dedicated to developing life-changing medicines
for people with serious diseases—often with limited or no
therapeutic options. We have a diverse portfolio of marketed
medicines and novel product candidates, from early- to late-stage
development, in neuroscience and oncology. Within these therapeutic
areas, we are identifying new options for patients by actively
exploring small molecules and biologics, and through innovative
delivery technologies and cannabinoid science. Jazz is
headquartered in Dublin, Ireland
and has employees around the globe, serving patients in nearly 75
countries. Please visit www.jazzpharmaceuticals.com for more
information.
Contacts:
Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland, +353 1 634 3211
U.S., +1 650 496 2717
Media:
Kristin
Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland, +353 1 637 2141
U.S., +1 215 867 4948
Logo -
https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_New_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302019563.html